Press Releases

    • June 13, 2018

    Nemaura Medical Inc. Reports Full Year Financial Results

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    May 30, 2018

    Nemaura Medical Signs Joint Collaboration Agreement for European Commercialization

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    May 15, 2018

    Nemaura Medical to Present at the UBS Global Healthcare Conference

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    April 9, 2018

    Nemaura Medical Appoints Bashir Timol Chief Business Officer

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    March 28, 2018

    Nemaura Medical Appoints The Ruth Group as Investor and Public Relations Counsel

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    March 6, 2018

    Nemaura Medical to Ring the Nasdaq Closing Bell

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    March 1, 2018

    Nemaura Announces Expansion of Manufacturing Capabilities for SugarBEAT® Commercial Launch

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    February 9, 2018

    Nemaura Medical Inc. Reports Third Quarter 2017 Financial Results

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    January 31, 2018

    Nemaura Announces Positive Results for its SugarBEAT® European Clinical Program

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more
    January 23, 2018

    Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (“Nemaura”) (OTCQB: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive continuous glucose...

    Read more